AU4295696A - Use of ligands specific to major histocompatibility complex-class i antigens for diagnosing endometriosis - Google Patents

Use of ligands specific to major histocompatibility complex-class i antigens for diagnosing endometriosis

Info

Publication number
AU4295696A
AU4295696A AU42956/96A AU4295696A AU4295696A AU 4295696 A AU4295696 A AU 4295696A AU 42956/96 A AU42956/96 A AU 42956/96A AU 4295696 A AU4295696 A AU 4295696A AU 4295696 A AU4295696 A AU 4295696A
Authority
AU
Australia
Prior art keywords
antigens
class
major histocompatibility
histocompatibility complex
ligands specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42956/96A
Inventor
Marie-Helene Lachapelle
Pierre Miron
Denis-Claude Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Medecine de la Reproduction de Montreal
Original Assignee
Institut de Medecine de la Reproduction de Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut de Medecine de la Reproduction de Montreal filed Critical Institut de Medecine de la Reproduction de Montreal
Publication of AU4295696A publication Critical patent/AU4295696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/806—Fertility tests
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU42956/96A 1994-12-28 1995-12-28 Use of ligands specific to major histocompatibility complex-class i antigens for diagnosing endometriosis Abandoned AU4295696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US365085 1982-04-02
US08/365,085 US5618680A (en) 1994-12-28 1994-12-28 Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
PCT/CA1995/000730 WO1996020404A1 (en) 1994-12-28 1995-12-28 Use of ligands specific to major histocompatibility complex-class i antigens for diagnosing endometriosis

Publications (1)

Publication Number Publication Date
AU4295696A true AU4295696A (en) 1996-07-19

Family

ID=23437416

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42956/96A Abandoned AU4295696A (en) 1994-12-28 1995-12-28 Use of ligands specific to major histocompatibility complex-class i antigens for diagnosing endometriosis

Country Status (4)

Country Link
US (1) US5618680A (en)
AU (1) AU4295696A (en)
CA (1) CA2206420A1 (en)
WO (1) WO1996020404A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376201B2 (en) 1994-12-28 2002-04-23 Procrea Biosciences Inc. Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
NZ513692A (en) * 1999-01-25 2001-09-28 Procrea Biosciences Inc Method and diagnostic kit for diagnosis of endometriosis
US6743595B1 (en) * 1999-01-25 2004-06-01 Metriogene Biosciences Inc. Method and diagnostic kit for diagnosis of endometriosis
US7268117B2 (en) 2003-07-11 2007-09-11 Praecis Pharmaceuticals Incorporated Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
US20060008876A1 (en) * 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
US8733963B2 (en) * 2009-03-12 2014-05-27 Bryan P. Sharpley Portable solar light tower

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
US4666845A (en) * 1983-12-16 1987-05-19 Sloan-Kettering Institute Monoclonal antibodies to ovarian, cervical and uterine human cancers and method of diagnosis
US4675286A (en) * 1985-01-28 1987-06-23 Aspen Diagnostics, Inc. Fetal cell separation and testing
EP0258322A1 (en) * 1986-02-26 1988-03-09 The University Of Melbourne Hla-b27 testing
CA2011704A1 (en) * 1989-03-07 1990-09-07 Nelson N.H. Teng Endometriosis diagnosis methods and reagents
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
CA2062675A1 (en) * 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
US5256543A (en) * 1991-05-10 1993-10-26 Sangstat Medical Corporation HLA typing

Also Published As

Publication number Publication date
US5618680A (en) 1997-04-08
WO1996020404A1 (en) 1996-07-04
CA2206420A1 (en) 1996-07-04

Similar Documents

Publication Publication Date Title
AU641860B2 (en) Fluorosilicone compounds and compositions for adhesive release liners
GB9422383D0 (en) Antibodies
IL118468A0 (en) Reagents for the preparation of radiopharmaceuticals
CZ2000509A3 (en) Non-steroidal ligands of estrogen receptor
SG44337A1 (en) Process for the preparation of vinyl acetate catalyst
AU638313B2 (en) Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
EP0696742A3 (en) Direct digital synthesis component test
AU4930993A (en) Coupled replication-translation methods and kits for protein synthesis
EP0369482A3 (en) Adapter for intake manifold
GB2292976B (en) Device for fastening turbochargers
HK1120494A1 (en) Novel compounds and methods for synthesis and therapy
AU4295696A (en) Use of ligands specific to major histocompatibility complex-class i antigens for diagnosing endometriosis
SG53279A1 (en) Fibrin-specific antibody for use as an antithrombotic agent
US5821048B1 (en) Methods kits and compositions for diagnosing papillomavirus infection
AU5688596A (en) Anti-cd14 antibodies for use in the induction of il-10 secre tion
GB9610897D0 (en) Supercharger
AU5317996A (en) Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor
AU3948395A (en) Synthesis of 6-azaandrostenones
AU1985795A (en) Hla-dm is involved in antigen presentation to t lymphocytes
AU3622495A (en) Improvements to engines
EP0792157A4 (en) Preparation of mhc-peptide complexes
IL110178A (en) Monoclonal antibodies specific to antigen-human MHC complex
AU2422595A (en) Measuring of bloodgases
AU536305B2 (en) Pipe exhaust clamp
AU5126296A (en) Cover member and hook coupling for same